Clinical trial
A Study of Rasburicase Treatment for Chemotherapy of Malignancy-Induced Hyperuricemia in Patients With a History of Asthma Allergies
NCT00186940 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Rasburicase Treatment for Chemotherapy of Malignancy-Induced Hyperuricemia in Patients With a History of Asthma Allergies
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- February 28, 2010
- Enrollment
- 16 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.